why is united health stock down

February 18, 2026

UnitedHealth Group’s stock is down mainly because investors were hit with a rare “double shock”: weaker-than-expected earnings and a surprise policy/regulatory outlook that points to falling revenue and pressured profits over the next couple of years.

The core reasons UNH is down

1. First revenue decline in decades

UnitedHealth told investors it expects 2026 revenue of “greater than” about 439 billion dollars, which is roughly a 2% drop from 2025 instead of the growth Wall Street was expecting.

Analysts were looking for around 454 billion dollars, so the guidance was meaningfully below consensus, breaking the long‑running narrative that this is a steady growth machine.

For a company that has not seen annual revenue contract since the late 1980s, this reversal triggered a major repricing of expectations and valuation.

2. Disappointing earnings and rising medical costs

The latest quarterly report came in as “unsatisfactory” to the market, even where headline earnings-per-share roughly met forecasts, because profit levels were far below prior-year results and margins are under pressure from higher care utilization.

UnitedHealth has been dealing with elevated medical cost trends and “heightened care activity” for several quarters, which earlier forced a cut to its full‑year profit outlook and then a withdrawal of guidance altogether.

That pattern—costs up, visibility down—made investors more sensitive to any further bad news, so the latest miss and cautious commentary hit especially hard.

3. Medicare & policy shock (Trump administration moves)

At almost the same time as the earnings release, the Trump administration signaled that Medicare Advantage payment rates would remain largely unchanged going forward, rather than rising enough to offset cost pressures.

Regulators also released an advance notice for 2027 Medicare Advantage capitation rates that points to tighter reimbursement and efforts to reduce perceived overpayments to plans.

Because UnitedHealth is heavily exposed to Medicare Advantage, flat or weaker rates plus higher utilization means margin compression, which the market quickly priced in.

4. Shrinking membership and portfolio “right‑sizing”

Management guided that UnitedHealthcare (the insurance arm) expects to cover up to about 2.8 million fewer people this year, with nearly half of that coming from Medicare Advantage membership losses.

The company is also “right‑sizing” its exposure to Medicaid and ACA exchange plans, which, together with regulatory changes, means divestitures, exits, and a smaller, riskier pool of members.

A new law nicknamed the “One Big Beautiful Bill Act” tightened Medicaid financing and made ACA Marketplace enrollment harder, which is expected to shrink public‑coverage markets and remove a chunk of UnitedHealth’s growth runway.

5. Cyberattack and other overhangs

UnitedHealth previously disclosed roughly 799 million dollars in lost full‑year revenue tied to the major cyberattack on its Change Healthcare subsidiary in early 2024, adding to the list of one‑off and structural hits to earnings power.

The company is still working through restructuring, including cost cuts and portfolio pruning, which can create near‑term charges and uncertainty even if management argues it will lead to a leaner business later.

On top of that, there is an ongoing Department of Justice investigation into Medicare Advantage billing practices, which keeps a regulatory cloud hanging over the stock.

What actually happened to the stock price?

After the latest guidance and policy news in late January 2026, UnitedHealth shares fell about 20% in a single session, trading down from roughly the mid‑350s to the low‑280s—one of the steepest one‑day drops in its history.

The sell‑off spilled over into other insurers like Humana and CVS Health, signaling that investors view this as a sector‑level problem, not just a company‑specific misstep.

Here’s a compact view of the main drivers:

html

<table>
  <tr>
    <th>Factor</th>
    <th>What changed</th>
    <th>Why it pushed the stock down</th>
  </tr>
  <tr>
    <td>2026 revenue outlook</td>
    <td>Guided to &gt;439B vs. ~454B expected, ~2% year‑over‑year decline.[web:1][web:3][web:9]</td>
    <td>Breaks long growth streak, forces investors to cut long‑term growth and valuation assumptions.</td>
  </tr>
  <tr>
    <td>Earnings quality</td>
    <td>Quarterly EPS roughly met estimates but was ~70% below same quarter in 2024; margin pressure from higher medical costs.[web:3][web:5]</td>
    <td>Signals structurally weaker profitability, not just a one‑off miss.</td>
  </tr>
  <tr>
    <td>Medicare policy</td>
    <td>Trump administration keeps Medicare Advantage rates largely unchanged; 2027 rate proposal points to tighter payments.[web:3][web:7]</td>
    <td>Reduces expected profit per member in a key growth business, especially with utilization rising.</td>
  </tr>
  <tr>
    <td>Membership trends</td>
    <td>Forecast up to 2.8M fewer covered lives in 2026; large losses in Medicare Advantage.[web:3][web:9]</td>
    <td>Less premium volume and weaker growth narrative for the franchise.</td>
  </tr>
  <tr>
    <td>Regulatory & legal overhang</td>
    <td>New law reshaping Medicaid/ACA markets; DOJ investigation into Medicare Advantage billing.[web:3][web:9]</td>
    <td>Increases uncertainty, risk of further margin and growth pressure.</td>
  </tr>
  <tr>
    <td>Cyberattack impact</td>
    <td>About 799M revenue hit from 2024 Change Healthcare cyberattack.[web:5]</td>
    <td>Adds to perception that earnings are being chipped away from multiple directions.</td>
  </tr>
  <tr>
    <td>Market reaction</td>
    <td>Stock dropped around 20% in a day, dragging the broader health‑insurance group lower.[web:1][web:3][web:9]</td>
    <td>Represents a major reset in how the market values UnitedHealth’s stability and growth.</td>
  </tr>
</table>

How forums and investors are talking about it

On investing forums, people are debating whether this is a temporary reset or a structural break in the UnitedHealth story, with some pointing to rising care costs and political risk as long‑term threats.

Others see the steep drop as an opportunity, arguing that UnitedHealth still has massive scale and diversified operations, and that current issues are “a reset, not a reversal of fortune,” echoing management’s framing.

There is also frustration that what was treated as a defensive, stable compounder suddenly traded more like a high‑beta stock when the combination of weak guidance and policy shock hit all at once.

Quick TL;DR

UnitedHealth stock is down because the company paired weak earnings with its first revenue‑decline outlook in decades, all while facing flat Medicare rates, rising medical costs, shrinking membership, regulatory and legal pressure, and lingering cyberattack impacts—together forcing investors to rethink its growth and safety profile.

Information gathered from public forums or data available on the internet and portrayed here.